Application Sponsors
ANDA 202970 | MYLAN LABS LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL-28 | 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG | 0 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-03-23 | |
LABELING; Labeling | SUPPL | 3 | AP | 2022-04-29 | STANDARD |
Submissions Property Types
CDER Filings
MYLAN LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 202970
[companyName] => MYLAN LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"LEVONORGESTREL AND ETHINYL ESTRADIOL","activeIngredients":"ETHINYL ESTRADIOL; LEVONORGESTREL","strength":"0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/23\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-03-23
)
)